NCT06000891 - A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 15, 2023

Primary Completion Date

February 11, 2025

Study Completion Date

March 21, 2025

Conditions

Safety and Tolerability

Interventions

DRUG

ZP7570

13 once-weekly subcutaneous injections in Part 1. 28 once-weekly subcutaneous injections in Part 2.

DRUG

Placebo

13 once-weekly subcutaneous injections in Part 1. 28 once-weekly subcutaneous injections in Part 2.

Trial Locations (1)

Profil Institut für Stoffwechselforschung GmbH, Neuss